Showing 1091-1100 of 3597 results for "".
Overcoming Real and Perceived Challenges in Medical Management of Actinic Keratoses
https://practicaldermatology.com/topics/general-topics/overcoming-real-and-perceived-challenges-in-medical-management-of-actinic-keratoses/21845/Everyone from prescribers to patients to pharmacists plays a role in the successful incorporation of medical AK management.Clinical Case Report: Severe Allergic Contact Dermatitis of Eyelids: When Topical and Oral Steroids Are Not an Option
https://practicaldermatology.com/topics/general-topics/clinical-case-report-severe-allergic-contact-dermatitis-of-eyelids-when-topical-and-oral-steroids-are-not-an-option/21878/Topical calcineurin inhibitors may present a therapeutic option for contact dermatitis of the eyelids.Topical Rejuvenation Options for the Hyperpigmentation Patient
https://practicaldermatology.com/topics/general-topics/PD0609_03-php/22812/Appropriate rejuvenation regimens can actually correct hyperpigmentation and not make it worse.High Risk SCC: What Factors Predict Recurrence and Metastasis?
https://practicaldermatology.com/topics/general-topics/PD1208_12-php/22609/Data shed light on risk factors associated with aggressive SCC, allowing dermatologists to identify and properly follow high-risk patients.New in My Practice: Rx/New Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-rxnew-products/23522/Case Report: Acquired Elastoic Hemangioma; Cosmetic Surgery Forum Resident Winners
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-acquired-elastoic-hemangioma-cosmetic-surgery-forum-resident-winners/21067/PRP: What Dermatologists Should Know
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/prp-what-dermatologists-should-know/20333/Long used in orthopedic medicine and made popular on social media, PRP has science to support its use in dermatology.Bimekizumab-bkzx Journal Scan: 4 Clinical Trials
https://practicaldermatology.com/topics/digital-supplement/bimekizumab-bkzx-journal-scan-4-clinical-trials/24128/Speed, depth, and durability from the first dual IL-17A/F inhibitor for the treatment of moderate to severe plaque psoriasis.Driving Practice Value: The Competitive Sale Process
https://practicaldermatology.com/topics/practice-management/driving-practice-value-the-competitive-sale-process/24007/The Placebo and Nocebo Effects in Dermatology
https://practicaldermatology.com/columns/clinical-focus-1/the-placebo-and-nocebo-effects-in-dermatology/23559/Increasing evidence suggests that these effects—though not fully understood—may be harnessed for patient care.